{"id":"NCT02504268","sponsor":"Bristol-Myers Squibb","briefTitle":"Effects of Abatacept in Patients With Early Rheumatoid Arthritis","officialTitle":"A Phase 3B, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC in Combination With Methotrexate Compared to Methotrexate Monotherapy in Achieving Clinical Remission in Adults With Early Rheumatoid Arthritis Who Are Methotrexate Naive","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09-03","primaryCompletion":"2017-01-16","completion":"2020-03-19","firstPosted":"2015-07-21","resultsPosted":"2019-04-08","lastUpdate":"2021-06-28"},"enrollment":994,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"Abatacept","otherNames":[]},{"type":"DRUG","name":"Methotrexate","otherNames":[]},{"type":"OTHER","name":"Abatacept Placebo","otherNames":[]},{"type":"OTHER","name":"Methotrexate Placebo","otherNames":[]}],"arms":[{"label":"Combination Therapy: Abatacept + Methotrexate","type":"EXPERIMENTAL"},{"label":"Methotrexate treatment","type":"ACTIVE_COMPARATOR"},{"label":"Abatacept Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Methotrexate Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine if abatacept is effective in the treatment of early rheumatoid arthritis.","primaryOutcome":{"measure":"Percentage of Participants in Simple Disease Activity Index (SDAI) Remission at Week 24","timeFrame":"Week 24","effectByArm":[{"arm":"Combination Therapy: Abatacept + Methotrexate (Cohort 1, IP)","deltaMin":21.3,"sd":null},{"arm":"Placebo + Methotrexate (Cohort 1, IP)","deltaMin":16,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2359"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":201,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Chile","Colombia","Czechia","Finland","France","Germany","Hungary","Israel","Italy","Japan","Mexico","Monaco","Netherlands","Peru","Poland","Qatar","Romania","Russia","Singapore","South Africa","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["39814436","37087459","36869251","36585217"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/s/US/English/USenHome","https://www.bms.com/researchers-and-partners/investigator-inquiry-form.html","https://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":451},"commonTop":["Nasopharyngitis","Nausea","Upper respiratory tract infection","Headache","Bronchitis"]}}